Specific inhibition of endogenous HMGB1 with antagonists, such as soluble receptor for advanced end glycosylation products (sRAGE), HMGB1 A box or an anti-HMGB1 antibody (Ab), has been shown to reverse the lethality of established sepsis (9, 10). Here, HMGB1 is linked to Sepsis.